Drug
Gsk5784283
Gsk5784283: highest development phase Phase 3, developed by GlaxoSmithKline. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| GSK5784283 NCT07780669 | Phase 3 | Pulmonary Disease, Chronic Obstructive |
| GSK5784283 NCT07782970 | Phase 3 | Nasal Polyps |
| GSK5784283 NCT07712393 | Phase 1 | Asthma |
Latest
No recent events.
Follow Gsk5784283 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.